B. Nebiyou Bekele

13.4k total citations · 4 hit papers
137 papers, 10.3k citations indexed

About

B. Nebiyou Bekele is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, B. Nebiyou Bekele has authored 137 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 53 papers in Molecular Biology and 40 papers in Pulmonary and Respiratory Medicine. Recurrent topics in B. Nebiyou Bekele's work include Lung Cancer Treatments and Mutations (19 papers), Statistical Methods in Clinical Trials (16 papers) and PI3K/AKT/mTOR signaling in cancer (12 papers). B. Nebiyou Bekele is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Statistical Methods in Clinical Trials (16 papers) and PI3K/AKT/mTOR signaling in cancer (12 papers). B. Nebiyou Bekele collaborates with scholars based in United States, Japan and Netherlands. B. Nebiyou Bekele's co-authors include Linda S. Elting, Ignacio I. Wistuba, Mark R. Gilbert, J. Peter Donnelly, Douglas E. Peterson, Judith E. Raber‐Durlacher, Dorothy Keefe, Edward Rubenstein, Martin Hauer‐Jensen and Stephen T. Sonis and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Statistical Association and Blood.

In The Last Decade

B. Nebiyou Bekele

136 papers receiving 10.1k citations

Hit Papers

Perspectives on cancer therapy-induced mucosal injury 2004 2026 2011 2018 2004 2004 2010 2007 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Perspectives on cancer therapy-induced mucosal injury
    2004 1.1k citations Linda S. Elting, B. Nebiyou Bekele et al. profile →
  2. Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents
    2004 670 citations B. Nebiyou Bekele et al. profile →
  3. Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System
    2010 513 citations B. Nebiyou Bekele, Mark R. Gilbert et al. profile →
  4. KRASMutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer
    2007 500 citations Natalie Ozburn, Diane D. Liu et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Nebiyou Bekele United States 56 3.9k 3.8k 3.3k 2.0k 1.4k 137 10.3k
Rosemarie Mick United States 72 3.5k 0.9× 6.2k 1.6× 2.6k 0.8× 952 0.5× 2.1k 1.5× 265 14.4k
Sandrine Faivre France 58 6.7k 1.7× 6.8k 1.8× 3.4k 1.0× 741 0.4× 2.2k 1.5× 286 14.9k
Anthony F. Shields United States 59 2.2k 0.6× 4.5k 1.2× 2.9k 0.9× 820 0.4× 2.0k 1.4× 360 11.9k
Mario E. Lacouture United States 67 3.2k 0.8× 9.5k 2.5× 3.1k 1.0× 1.5k 0.7× 705 0.5× 375 15.1k
Apostolia M. Tsimberidou United States 58 4.8k 1.2× 5.4k 1.4× 3.3k 1.0× 2.5k 1.2× 4.2k 2.9× 445 14.5k
Ulrich Keilholz Germany 65 6.1k 1.6× 9.2k 2.5× 2.2k 0.7× 388 0.2× 1.8k 1.2× 477 15.5k
Sanjiv S. Agarwala United States 48 4.2k 1.1× 6.1k 1.6× 1.9k 0.6× 675 0.3× 675 0.5× 209 9.7k
Jan B. Vermorken Belgium 59 3.4k 0.9× 7.0k 1.9× 3.1k 0.9× 513 0.3× 1.7k 1.2× 371 12.8k
George Fountzilas Greece 54 3.1k 0.8× 7.7k 2.0× 3.7k 1.1× 568 0.3× 2.1k 1.5× 576 12.8k
Alberto Ocaña Spain 51 3.8k 1.0× 7.3k 1.9× 2.5k 0.8× 576 0.3× 2.5k 1.7× 302 12.3k

Countries citing papers authored by B. Nebiyou Bekele

Since Specialization
Citations

This map shows the geographic impact of B. Nebiyou Bekele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Nebiyou Bekele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Nebiyou Bekele more than expected).

Fields of papers citing papers by B. Nebiyou Bekele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Nebiyou Bekele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Nebiyou Bekele. The network helps show where B. Nebiyou Bekele may publish in the future.

Co-authorship network of co-authors of B. Nebiyou Bekele

This figure shows the co-authorship network connecting the top 25 collaborators of B. Nebiyou Bekele. A scholar is included among the top collaborators of B. Nebiyou Bekele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Nebiyou Bekele. B. Nebiyou Bekele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bekele, B. Nebiyou, et al.. (2025). Nil Per Os in the Emergency Department: A Quantitative Study on Fasting Before Presumptive Emergency Surgery. Journal of Emergency Nursing. 51(4). 675–683.
2.
Groot, John de, Yuji Piao, Hai T. Tran, et al.. (2011). Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept. Clinical Cancer Research. 17(14). 4872–4881. 51 indexed citations
3.
Kim, Min P., Ying Chen, B. Nebiyou Bekele, et al.. (2011). Activating Enhancer-Binding Protein-2β Nucleolar Localization Predicts Poor Survival After Stage I Non-Small Cell Lung Cancer Resection. The Annals of Thoracic Surgery. 92(3). 1044–1050. 4 indexed citations
4.
Solis, Luisa M., Carmen Behrens, Wenli Dong, et al.. (2010). Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features. Clinical Cancer Research. 16(14). 3743–3753. 357 indexed citations
5.
Hu, Bo, B. Nebiyou Bekele, & Yuan Ji. (2010). Adaptive dose insertion in early phase clinical trials. Clinical Trials. 10(2). 216–224. 13 indexed citations
6.
Wierda, William G., E. Lin, Shao-Qing Kuang, et al.. (2010). Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics. 5(6). 499–508. 92 indexed citations
7.
Gaur, Puja, Wayne L. Hofstetter, B. Nebiyou Bekele, et al.. (2010). Comparison Between Established and the Worldwide Esophageal Cancer Collaboration Staging Systems. The Annals of Thoracic Surgery. 89(6). 1797–1804.e3. 18 indexed citations
8.
Ma, Wanlong, Hagop M. Kantarjian, B. Nebiyou Bekele, et al.. (2009). Proteasome Enzymatic Activities in Plasma as Risk Stratification of Patients with Acute Myeloid Leukemia and Advanced-Stage Myelodysplastic Syndrome. Clinical Cancer Research. 15(11). 3820–3826. 40 indexed citations
9.
Prudkin, Ludmila, Carmen Behrens, Diane D. Liu, et al.. (2008). Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer. Clinical Cancer Research. 14(1). 41–47. 68 indexed citations
10.
Seo, Hye‐Sook, Diane D. Liu, B. Nebiyou Bekele, et al.. (2008). Cyclic AMP Response Element-Binding Protein Overexpression: A Feature Associated with Negative Prognosis in Never Smokers with Non–Small Cell Lung Cancer. Cancer Research. 68(15). 6065–6073. 85 indexed citations
11.
Lahat, Guy, Daniel Tuvin, C. Wei, et al.. (2008). New Perspectives for Staging and Prognosis in Soft Tissue Sarcoma. Annals of Surgical Oncology. 15(10). 2739–2748. 110 indexed citations
12.
Tefferi, Ayalew, Srđan Verstovšek, G. Barosi, et al.. (2008). Pomalidomide Therapy in Anemic Patients with Myelofibrosis: Results from a Phase-2 Randomized Multicenter Study. Blood. 112(11). 663–663. 5 indexed citations
13.
Johnson, D. Gale, Hong Jiang, Jing Xu, et al.. (2007). Transgenic E2F1 Expression in the Mouse Brain Induces a Human-Like Bimodal Pattern of Tumors. Cancer Research. 67(9). 4005–4009. 19 indexed citations
14.
Stewart, David J., et al.. (2007). PD6-1-5: Dose-response relationships in extensive small cell lung cancer and implications for resistance mechanisms.. Journal of Thoracic Oncology. 2(8). S426–S426. 1 indexed citations
15.
Jin, Quanri, Lei Feng, Carmen Behrens, et al.. (2007). Implication of AMP-Activated Protein Kinase and Akt-Regulated Survivin in Lung Cancer Chemopreventive Activities of Deguelin. Cancer Research. 67(24). 11630–11639. 77 indexed citations
16.
Jones, Jeffrey A., et al.. (2006). Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Supportive Care in Cancer. 14(6). 505–515. 114 indexed citations
17.
Lee, J. Jack, B. Nebiyou Bekele, Xian Zhou, et al.. (2006). Decision Analysis for Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer. Journal of Clinical Oncology. 24(22). 3597–3603. 50 indexed citations
18.
Lee, Ok-Hee, Jing Xu, Juàn Fueyo, et al.. (2006). Expression of the Receptor Tyrosine Kinase Tie2 in Neoplastic Glial Cells Is Associated with Integrin β1-Dependent Adhesion to the Extracellular Matrix. Molecular Cancer Research. 4(12). 915–926. 55 indexed citations
19.
Schiff, Bradley A., Samar A. Jasser, Maher N. Younes, et al.. (2004). Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer. Clinical Cancer Research. 10(24). 8594–8602. 142 indexed citations
20.
Myers, Jeffrey N., F. Christopher Holsinger, B. Nebiyou Bekele, et al.. (2002). Targeted Molecular Therapy for Oral Cancer With Epidermal Growth Factor Receptor Blockade. Archives of Otolaryngology - Head and Neck Surgery. 128(8). 875–875. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosemarie Mick Breakdown of academic impact, for papers by Sandrine Faivre Breakdown of academic impact, for papers by Anthony F. Shields Breakdown of academic impact, for papers by Mario E. Lacouture Breakdown of academic impact, for papers by Apostolia M. Tsimberidou Breakdown of academic impact, for papers by Ulrich Keilholz Breakdown of academic impact, for papers by Sanjiv S. Agarwala Breakdown of academic impact, for papers by Jan B. Vermorken Breakdown of academic impact, for papers by George Fountzilas Breakdown of academic impact, for papers by Alberto Ocaña
Rankless by CCL
2026